Introduction
Infantile hemangiomas (IHs) are the most common benign tumors of infancy[1], and the incidence ranges from 4% to 5%. They are more common in females and Caucasians, and are associated with low birth weight and prematurity of infants. Although IHs are benign and regress spontaneously[2], significant morbidity and mortality can occur during any phase, in particular during the proliferative phase of tumors. Intervention is indicated if the IHs are expected to cause morbidities.